![Cbd Vs Hemp Gummies: Which Is Right For Your Wellness Routine? [Tz8JKLqMk37]](https://i0.wp.com/cedclinic.com/wp-content/uploads/2026/07/ced-pexels-5021600.jpg?resize=150%2C150&ssl=1 "Cbd Vs Hemp Gummies: Which Is Right For Your Wellness Routine? 14")
Pipeline Progress Drives Investor Focus at Agentix – Ad-hoc-news.de
Endocannabinoid system modulators AGTX-2004 and AGTX-2003 are advancing through clinical development, attracting significant investor focus. These cannabinoid-based therapeutics may offer new treatment options pending clinical validation. Clinicians…
Endocannabinoid System Research: Cannabis & Teen Mental Health
This study highlights internalising symptoms adolescent cannabis use risk, showing that anxiety and depression symptoms predict cannabis initiation. Adolescents with these symptoms are more likely to use cannabis frequently. Understanding this risk can…
Clinical Research on Mental Health in Retired Athletes
Mental health retired athletes clinical research highlights elevated depression, anxiety, and cognitive concerns in former high contact sport professionals. Key factors include concussion history, career transitions, and social support loss. Early…
Senate Bill Could Allow Off-Duty Fire and Rescue Workers to Use Medical Marijuana
A Maryland Senate bill proposes allowing medical marijuana use for firefighters off-duty, addressing occupational health concerns. This legislation supports medical marijuana use for firefighters managing conditions like PTSD and chronic pain. Clinicians…
Endocannabinoid System Research: GLP-1 and Mental Health Insights
GLP-1 receptor agonists mental health effects were examined using Mendelian randomization to assess their impact on common mental illnesses. This genetic study suggests a potential causal link between GLP-1 receptor agonists and reduced schizophrenia…
Cannabis Derivatives for Autism: Clinical Evidence & Research
Several randomized clinical trials have examined cannabis derivatives autism spectrum disorder symptoms. Findings suggest potential benefits for behavioral challenges and social functioning. The evidence base remains limited, so no definitive clinical…
Endocannabinoid System & Teen Anxiety: Clinical Evidence
Internalising symptoms adolescent cannabis use is linked to increased risk of initiation and escalation among teens. This clinical evidence highlights the importance of screening for anxiety and depression in adolescents. Understanding these risks can…
Cannabinoids for Children: Clinical Evidence Reviewed
Current cannabinoids pediatric safety evidence spans 276 studies covering plant-derived and pharmaceutical formulations for children under 18. This clinical review synthesizes safety and reported benefits from interventional trials and observational…
Endocannabinoid System Clinical Research: Athlete Mental Health Insights
Endocannabinoid system clinical research retired athletes reveals key insights into mental health challenges faced by retired professional athletes. This research highlights factors influencing depression and anxiety post-retirement. Clinicians should…
Patient Protect Launches to Tackle Discrimination Against UK Medical Cannabis Patients
Medical cannabis patient discrimination remains a significant barrier in the UK. Patient Protect launches to tackle these challenges and support treatment adherence. This initiative aims to reduce stigma and improve outcomes for patients prescribed…